Etiology-specific assessment of predictors of long-term survival in chronic systolic heart failure

被引:6
作者
Franke, Jennifer [1 ]
Zugck, Christian [1 ]
Hochadel, Matthias [2 ]
Hack, Anna [1 ]
Frankenstein, Lutz [1 ]
Zhao, Jingting Desiree [1 ]
Ehlermann, Philipp [1 ]
Nelles, Manfred [1 ]
Zeymer, Uwe [3 ]
Winkler, Ralph [3 ]
Zahn, Ralf [3 ]
Katus, Hugo A. [1 ]
Senges, Jochen [2 ]
机构
[1] Heidelberg Univ, Dept Cardiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Inst Herzinfarktforschung, Ludwigshafen, Germany
[3] Heart Ctr Ludwigshafen, Dept Cardiol, Ludwigshafen, Germany
来源
IJC HEART & VASCULATURE | 2015年 / 7卷
关键词
Heart failure; Dilated cardiomyopathy; Ischemic cardiomyopathy; Prognosis;
D O I
10.1016/j.ijcha.2015.01.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We sought to identify prognostic factors of long-term mortality, specific for the underlying etiology of chronic systolic heart failure (CHF). Methods and results: Between 1995 and 2009 baseline characteristics, treatment and follow-up data from 2318 CHF-patients due to ischemic (ICM; 1100 patients) or dilated cardiomyopathy (DCM; 1218 patients) were prospectively compared. To calculate hazard ratios with 95%-confidence intervals cox regression was used. We respectively established etiology-specific multivariable models of independent prognostic factors. During the follow-up period of up to 14.8 years (mean = 53.1 +/- 43.5 months; 10,264 patient-years) 991 deaths (42.8%) occurred. In the ICM-cohort, 5-year-survivalwas 53.4% (95% CI: 49.9-56.7%), whereas in DCM-patients itwas higher (68.1% (95% CI: 65.1-71.0%)). Age, ejection fraction, or hyponatremiawere independent predictors formortality in both cohorts, whereas diabetes, COPD, atrial fibrillation and a heart rate of >= 80/min carried independent predictive power only in ICM-patients. Conclusion: This study demonstrates the disparity of prognostic value of clinically derived risk factors between the two main causes of CHF. The effects of covariables in DCM-patients were lower, suggesting a less modifiable disease through risk factors considering mortality risk. An etiology-specific prognosticmodel may improve accuracy of survival estimations in CHF. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 45 条
[1]   Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation [J].
Aaronson, KD ;
Schwartz, JS ;
Chen, TM ;
Wong, KL ;
Goin, JE ;
Mancini, DM .
CIRCULATION, 1997, 95 (12) :2660-2667
[2]   Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure [J].
Adams, KF .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (09) :S4-S13
[3]   RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model [J].
Aleshin, Alexey ;
Ananthakrishnan, Radha ;
Li, Qing ;
Rosario, Rosa ;
Lu, Yan ;
Qu, Wu ;
Song, Fei ;
Bakr, Soliman ;
Szabolcs, Matthias ;
D'Agati, Vivette ;
Liu, Rui ;
Homma, Shunichi ;
Schmidt, Ann Marie ;
Yan, Shi Fang ;
Ramasamy, Ravichandran .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (04) :H1823-H1832
[4]   EFFECT OF LONG-TERM ENALAPRIL THERAPY ON NEUROHORMONES IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION [J].
BENEDICT, CR ;
FRANCIS, GS ;
SHELTON, B ;
JOHNSTONE, DE ;
KUBO, SH ;
KIRLIN, P ;
NICKLAS, J ;
LIANG, CS ;
KONSTAM, MA ;
GREENBERG, B ;
YUSUF, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (16) :1151-1157
[5]  
Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7
[6]   Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey [J].
Cleland, JGF ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Eastaugh, J ;
Follath, F ;
Freemantle, N ;
Gavazzi, A ;
van Gilst, WH ;
Hobbs, FDR ;
Korewicki, J ;
Madeira, HC ;
Preda, I ;
Swedberg, K ;
Widimsky, J .
LANCET, 2002, 360 (9346) :1631-1639
[7]   The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].
Cleland, JGF ;
Swedberg, K ;
Follath, F ;
Komajda, M ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Gavazzi, A ;
Hobbs, R ;
Korewicki, J ;
Madeira, HC ;
Moiseyev, VS ;
Preda, I ;
van Gilst, WH ;
Widimsky, J ;
Freemantle, N ;
Eastaugh, J ;
Mason, J .
EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463
[8]   Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats [J].
Cox, MJ ;
Sood, HS ;
Hunt, MJ ;
Chandler, D ;
Henegar, JR ;
Aru, GM ;
Tyagi, SC .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (04) :H1197-H1205
[9]   Mechanisms of Pharmacogenomic Effects of Genetic Variation within the Cardiac Adrenergic Network in Heart Failure [J].
Dorn, Gerald W., II ;
Liggett, Stephen B. .
MOLECULAR PHARMACOLOGY, 2009, 76 (03) :466-480
[10]   Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [J].
Dries, DL ;
Exner, DV ;
Gersh, BJ ;
Domanski, MJ ;
Waclawiw, MA ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :695-703